Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard R Winkelmann

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Circulation|October 27, 2004
Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health studyWinfried März, Hubert Scharnagl, Karl Winkler, et al.
Clinical Endocrinology|February 17, 2007
Implications of resistin plasma levels in subjects undergoing coronary angiographyStefan Pilz, Gisela Weihrauch, Ursula Seelhorst, et al.
Clinical Chemistry|April 21, 2007
N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health StudyWinfried März, Beate Tiran, Ursula Seelhorst, et al.
Diabetes Care|September 14, 2011
Additional use of glycated hemoglobin for diagnosis of type 2 diabetes in people undergoing coronary angiography reveals a subgroup at increased cardiovascular riskGuenther Silbernagel, Marcus E Kleber, Tanja B Grammer, et al.
Molecular Genetics and Metabolism|June 13, 2006
The angiotensin-I converting enzyme I/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study)Tanja B Grammer, Wilfried Renner, Sabine von Karger, et al.
Journal of Lipid Research|March 16, 2010
The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortalityGuenther Silbernagel, Guenter Fauler, Michael M Hoffmann, et al.
Clinical Chemistry|March 1, 2007
The -50G>T polymorphism in the promoter of the CYP2J2 gene in coronary heart disease: the Ludwigshafen Risk and Cardiovascular Health studyMichael M Hoffmann, Peter Bugert, Ursula Seelhorst, et al.
Clinical Chemistry|December 23, 2006
Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study)Andreas Meinitzer, Ursula Seelhorst, Britta Wellnitz, et al.
Atherosclerosis|June 3, 2011
Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiographyHarald Sourij, Andreas Meinitzer, Stefan Pilz, et al.
The Journal of Clinical Endocrinology and Metabolism|August 17, 2006
Adiponectin and mortality in patients undergoing coronary angiographyStefan Pilz, Harald Mangge, Britta Wellnitz, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Circulation|October 27, 2004
Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health studyWinfried März, Hubert Scharnagl, Karl Winkler, et al.
Clinical Endocrinology|February 17, 2007
Implications of resistin plasma levels in subjects undergoing coronary angiographyStefan Pilz, Gisela Weihrauch, Ursula Seelhorst, et al.
Clinical Chemistry|April 21, 2007
N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health StudyWinfried März, Beate Tiran, Ursula Seelhorst, et al.
Diabetes Care|September 14, 2011
Additional use of glycated hemoglobin for diagnosis of type 2 diabetes in people undergoing coronary angiography reveals a subgroup at increased cardiovascular riskGuenther Silbernagel, Marcus E Kleber, Tanja B Grammer, et al.
Molecular Genetics and Metabolism|June 13, 2006
The angiotensin-I converting enzyme I/D polymorphism is not associated with type 2 diabetes in individuals undergoing coronary angiography. (The Ludwigshafen Risk and Cardiovascular Health Study)Tanja B Grammer, Wilfried Renner, Sabine von Karger, et al.
Journal of Lipid Research|March 16, 2010
The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortalityGuenther Silbernagel, Guenter Fauler, Michael M Hoffmann, et al.
Clinical Chemistry|March 1, 2007
The -50G>T polymorphism in the promoter of the CYP2J2 gene in coronary heart disease: the Ludwigshafen Risk and Cardiovascular Health studyMichael M Hoffmann, Peter Bugert, Ursula Seelhorst, et al.
Clinical Chemistry|December 23, 2006
Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study)Andreas Meinitzer, Ursula Seelhorst, Britta Wellnitz, et al.
Atherosclerosis|June 3, 2011
Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiographyHarald Sourij, Andreas Meinitzer, Stefan Pilz, et al.
The Journal of Clinical Endocrinology and Metabolism|August 17, 2006
Adiponectin and mortality in patients undergoing coronary angiographyStefan Pilz, Harald Mangge, Britta Wellnitz, et al.
Pageof 8